Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Betamethasone[1] Betamethasone (Betamethasone valerate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate, BETAMETHASONE VALERATE),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 28, 83, 90, 96, 235 💬
2Betamethasone acibutate[1] Betamethasone (Betamethasone valerate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate, BETAMETHASONE VALERATE),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
3Betamethasone mouthwash[1] Betamethasone (Betamethasone valerate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate, BETAMETHASONE VALERATE),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 56 💬
4Betamethasone oral solution period 1 and period 2[1] Betamethasone (Betamethasone valerate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate, BETAMETHASONE VALERATE),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
5Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 MG IM once A DAY FOR four days[1] Betamethasone (Betamethasone valerate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate, BETAMETHASONE VALERATE),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
6Betamethasone solution AS intramuscular injection period 1 and period 2[1] Betamethasone (Betamethasone valerate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate, BETAMETHASONE VALERATE),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
7Intra-articular compound betamethasone----[1] 46 💬
8Intraarticular betamethasone----[1] 46 💬